drugset / Trial / NCT07623824
A Phase III Clinical Trial to Evaluate the Efficacy and Safety of Octreotide Long-acting Injection in Patients With Acromegaly
RandomizedParallel-groupOpen-labelTreatment
Summary
he purpose of this study is to evaluate the efficacy and safety of SYHX2008 injection in in patients with acromegaly.
Timeline
- Start
- 2026-05-31
- Primary completion
- 2029-07-31
- Completion
- 2029-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Octreotide | Peptide | — | Intramuscular |
| Subject | SYHX2008 | Unknown | — | Subcutaneous |